Early Events in B Lymphocyte Activation

Subbarao Bondada1, Amy Troyer1, Ralph L. Chelvarajan1

1 University of Kentucky, Lexington, Kentucky
Publication Name:  Current Protocols in Immunology
Unit Number:  Unit 3.9
DOI:  10.1002/0471142735.im0309s57
Online Posting Date:  November, 2003
GO TO THE FULL TEXT: PDF or HTML at Wiley Online Library

Abstract

B cell activation can be quantitated indirectly by assaying antibody production or directly by measuring cellular changes that occur immediately after exposure to an activation signal. This unit provides methods for the latter (direct) approach‐‐namely, methods for quantifying early parameters of B cell activation such as increases in intracellular ionized calcium concentration [Ca2+]I, cell size, and MHC class II‐antigen expression. These assays are not so much B cell specific as activation specific; as such they are a useful means of providing information about cellular events that are independent of antibody secretion. While the protocols included in this unit have been specifically designed for use with murine B cells, they can also be used with B cells obtained from other species. In addition, the method described here also applies to T cells.

     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Table of Contents

  • Basic Protocol 1: Bcr‐Induced Changes in Intracellular Calcium in B Cells
  • Basic Protocol 2: Analysis of Protein Tyrosine Phosphorylation
  • Basic Protocol 3: Analysis of Cell Size and Expression of Molecules Indicative of B Cell Activation
  • Reagents and Solutions
  • Commentary
  • Literature Cited
  • Figures
  • Tables
     
 
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Materials

Basic Protocol 1: Bcr‐Induced Changes in Intracellular Calcium in B Cells

  Materials
  • Gey's solution (see recipe), 4°C
  • Hanks balanced salt solution (HBSS; appendix 2A)/5% FBS
  • IF12 or RPMI medium (unit 3.8) containing 10% FBS
  • DMSO, anhydrous
  • INDO‐1 AM (Molecular Probes)
  • FITC‐anti‐B220 (Sigma or BD PharMingen)
  • HBSS ( appendix 2A), 4°C
  • 1.0 mM ionomycin (Calbiochem)
  • F(ab′) 2 anti‐IgM (µ chain specific; ICN Biomedicals) or anti‐IgD (BD PharminGen or Southern Biotechnology)
  • 12 × 75–mm tubes with caps suitable for use on the given flow cytometer
  • Flow cytometer (i.e., BD PharMingen FACS Vantage, Beckman‐Coulter Cytomics FC‐500 or EPICS, Cytomation Mo‐Flo, or any instrument that has a laser to excite Indo‐1 in the UV range, and FITC and phycoerythrin in the visible range)
  • Additional reagents and equipment for preparation of murine spleen cells (unit 3.4) and calculating calcium concentration (unit 5.5)

Basic Protocol 2: Analysis of Protein Tyrosine Phosphorylation

  Materials
  • Serum‐free IF12 or RPMI medium (unit 3.8)
  • 25 µg/ml F(ab′) 2 anti‐IgM (µ‐chain specific; ICN Biomedicals)
  • 1× PBS, pH 7.2 ( appendix 2A), with and without phosphatase inhibitors (i.e., 10 mM NaF and 1 mM Na 3VO 4), 4°C
  • Lysis buffer (see recipe)
  • BCA Protein Assay reagent (Pierce)
  • 1.5% BSA in 1× TBST (see recipe)
  • RC20:HRPO (BD PharMingen, Transduction Laboratories) or HRP‐conjugated 4G10 (Upstate) anti‐phosphotyrosine antibody in 1.5% BSA/1× TBST
  • 1× TBST (see recipe)
  • Enhanced chemiluminescence kit (Perkin‐Elmer Life Sciences or Pierce)
  • Immobilon‐P membrane (Millipore)
  • Additional reagents and equipment for purifying B lymphocytes depleted of red blood cells (see protocol 1 and unit 3.8), SDS‐PAGE (unit 8.4), protein blotting (unit 8.10), autoradiography ( appendix 3J), and immunoprecipitation (unit 8.3)

Basic Protocol 3: Analysis of Cell Size and Expression of Molecules Indicative of B Cell Activation

  Materials
  • Purified resting B cells (unit 3.8)
  • IF12 or RPMI (unit 3.8) with 5% FBS
  • 25 µg/ml F(ab′) 2 anti‐µ (ICN Biomedicals), 1.0 µg/ml anti‐CD40 (clone 1C1D; Southern Biotechnology or eBioscience), or 1.0 µg/ml LPS (Sigma)
  • FACS buffer (see recipe)
  • 10 mg/ml 2.4G2 anti‐Fc receptor antibody (BD PharMingen)
  • FITC‐anti‐mouse‐MHC class II (clones MKD6, 14.4.4 and M5/114.5.2), ‐CD80, ‐CD86, or ‐CD138 (BD PharMingen, Sigma, or equivalent)
  • 1× PBS ( appendix 2A)
  • Fixing solution (see recipe; optional)
  • 96‐, 48‐, or 24‐well plates
  • Additional reagents and materials for FACS analysis (Chapter 5)
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library

Figures

Videos

Literature Cited

Literature Cited
   Angelin‐Duclos, C., Cattoretti, G., Lin, K.‐I., and Calame, K. 2000. Commitment of B lymphocytes to a plasma cell fate is associated with blimp‐1 expression in vivo. J. Immunol. 165:5462‐5471.
   Baluyut, A.R. and Subbarao, B. 1988. The synergic effects of anti‐IgM and monoclonal anti‐Ia antibodies in induction of murine B lymphocyte activation. J. Mol. Cell Immunol. 4:45‐57.
   Baluyut, A.R., Pollok, K.E., and Bondada, S. 1993. Molecular events in B lymphocyte activation: Consequences of signals transduced through MHC class II molecules. Cell. Immunol. 147:353‐366.
   Buhl, A.M., Pleiman, C.M., Rickert, R.C., and Cambier, J.C. 1997. Qualitative regulation of B cell antigen receptor signaling by CD19: Selective requirement for PI3‐Kinase activation, inositol‐1,4,5‐triphosphate production and Ca2+ mobilization. J. Exp. Med. 186:1897‐1910.
   Calame, K.L. 2001. Plasma cells: Finding new light at the end of B cell development. Nat. Immunol. 2:1103‐1108.
   Carreno, B.M. and Collins, M. 2002. The B7 family of ligands and its receptors: New pathways for costimulation and inhibition of immune responses. Annu. Rev. Immunol. 20:29‐53.
   Chelvarajan, R.L., Raithatha, R., Venkataraman, C., Kaul, R., Robertson, D.A., and Bondada, S. 1999. CpGoligonucleotides overcome the unresponsiveness of neonatal B cells to stimulation with the thymic independent stimuli, anti‐IgM and TNP‐Ficoll. Eur. J. Immunol. 29:2808‐2818.
   DeFranco, A.L. 2001. Vav and the B cell signalosome. Nat. Immunol. 2:482‐484.
   Fischer, G.M., Solt, L.A., Hastings, W.D., Yang, K., Gerstein, R.M., Nikolajczyk, B.S., Clarke, S.H., and Rothstein, T.L. 2001. Splenic and peritoneal B‐1 cells differ in terms of transcriptional and proliferative features that separate peritoneal B‐1 from splenic B‐2 cells. Cell Immunol. 213:62‐71.
   Foy, T.M., Aruffo, A., Bajorath, J., Buhlman, J.E., and Noelle, R.J. 1996. Immune regulation by CD40 and its ligand GP39. Annu. Rev. Immunol. 14:591‐617.
   Gauld, S.B., Dal Porto, J.M., and Camvier, J.C. 2002. B cell antigen receptor signaling: Roles in cell development and disease. Science 296:1641‐1642.
   Hathcock, K.S. and Hodes, R.J. 1996. Role of the CD28‐B7 costimulatory pathways in T cell‐dependent B cell responses. Adv. Immunol. 62:131‐166.
   Hathcock, K.S., Laszlo, G., Pucillo, C., Linsley, P., and Hodes, R.J. 1994. Comparative analysis of B7‐1 and B7‐2 costimulatory ligands: Expression and function. J. Exp. Med. 180:631‐640.
   Healy, J.I. and Goodnow, C.C. 1998. Positive versus negative signaling by lymphocyte antigen receptors. Annu. Rev. Immunol. 16:645‐670.
   Hempel, W.M., Schatzman, R.C., and DeFranco, A.L. 1992. Tyrosine phosphorylation of phospholipase C‐γ2 upon cross‐linking of membrane Ig on murine B lymphocytes. J. Immunol. 148:3021‐3027.
   Justement, L.B. 2000. Signal transduction via the B‐cell antigen receptor: The role of protein tyrosine kinases and protein tyrosine phosphatases. Curr. Top. Microbiol. Immunol. 245:1‐51.
   Krieg, A.M., Yi, A.K., Matson, S., Waldschmidt, T.J., Bishop, G.A., Teasdale, R., Koretzky, G.A., and Klinman, D.M. 1995. CpG motifs in bacterial DNA trigger direct B‐cell activation. Nature 374:546‐549.
   Lane, P.J., McConnell, F.M., Schieven, G.L., Clark, E.A., and Ledbetter, J.A. 1990. The role of class II molecules in human B cell activation. Association with phosphatidyl inositol turnover, protein tyrosine phosphorylation, and proliferation. J. Immunol. 144:3684‐3692.
   Mongini, P.K., Blessinger, C.A., Highet, P.F., and Inman, J.K. 1992. Membrane IgM‐mediated signaling of human B cells. Effect of increased ligand binding site valency on the affinity and concentration requirements for inducing diverse stages of activation. J. Immunol. 148:3892‐3901.
   Muthusamy, N., Baluyut, A.R., and Subbarao, B. 1991. Differential regulation of surface Ig‐ and Lyb2‐mediated B cell activation by cyclic AMP. I. Evidence for alternative regulation of signaling through two different receptors linked to phosphatidylinositol hydrolysis in murine B cells. J. Immunol. 147:2483‐2492
   Muzio, M., Polentarutti, N., Bosisio, D., Prahladan, M.K., and Mantovani, A. 2000. Toll‐like receptors: A growing family of immune receptors that are differentially expressed and regulated by different leukocytes. J. Leukoc. Biol. 67:450‐456.
   Noelle, R., Krammer, P.H., Ohara, J., Uhr, J.W., and Vitetta, E.S. 1984. Increased expression of Ia antigens on resting B cells: An additional role for B‐cell growth factor. Proc. Natl. Acad. Sci. U.S.A. 81:6149‐6153.
   Rabinovitch, P.S., June, C.H., Grossmann, A., and Ledbetter, J.A. 1986. Heterogeneity among T cells in intracellular free calcium responses after mitogen stimulation with PHA or anti‐CD3. Simultaneous use of Indo‐1 and immunofluorescence with flow cytometry. J Immunol. 137:952‐961.
   Ransom, J.T., Chen, M., Sandoval, V.M., Pasternak, J.A., Digiusto, D., and Cambier, J.C. 1988. Increased plasma membrane permeability to Ca2+ in anti‐ Ig‐stimulated B lymphocytes is dependent on activation of phosphoinositide hydrolysis. J. Immunol. 140:3150‐3155.
   Saijo, K., Schmedt, C., Su, I.H., Karasuyama, H., Lowell, C.A., Reth, M., Adachi, T., Patke, A., Santana, A., and Tarakhovsy, A. 2003. Essential role of Src‐family protein tyrosine kinases in NF‐κB activation during B cell development. Nat. Immunol. 4:274‐279.
   Satterthwaite, A.B., Li, Z., and Witte, O.N. 1988. Btk function in B cell development and response. Sem. Immunol. 10:309‐316.
   Sen, G., Wu, H.J., Bikah, G., Venkataraman, C., Robertson, D.A., Snow, E.C., and Bondada, S. 2002. Defective CD19‐dependent signaling in B‐1a and B‐1b B lymphocyte subpopulations. Mol. Immunol. 39:57‐68.
   Suvas, S., Singhm, V., Sahdev, S., Vohra, H., and Agrewala, J.N. 2002. Distinct role of CD80 and CD86 in the regulation of the activation of B cell and B cell lymphoma. J. Biol. Chem. 277:7766‐7775.
   Suzuki, H., Terauchi, Y., Fujiwara, M., Aizawa, S., Yazaki, Y., Kadowaki, T., and Koyasu, S. 1999. Xid‐like immunodeficiency in mice with disruption of the p85α subunit of phosphoinositide 3‐kinase. Science 283:390‐392.
   Tedder, T.F., Inaoki, M., and Sato, S. 1997. The CD19‐CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity 6:107‐118.
   Thompson, C. B., Scher, I., Schaefer, M.E., Lindsten, T., Finkelman, F.D., and Mond, J.J. 1984. Size‐dependent B lymphocyte subpopulations: Relationship of cell volume to surface phenotype, cell cycle, proliferative response, and requirements for antibody production to TNP‐Ficoll and TNP‐BA. J. Immunol. 133:2333‐2342.
   Venkataraman, C., Lu, P.‐J., Buhl, A.M., Chen, C.‐S., Cambier, J.C., and Bondada, S. 1998a. CD72 mediated B cell activation involves recruitment of CD19 and activation of phosphatidylinositol 3‐kinase. Eur. J. Immunol. 28:3003‐3016.
   Venkataraman, C., Muthusamy, N., Muthukkumar, S., and Bondada, S. 1998b. Activation of lyn, blk, and btk but not syk in CD72‐stimulated B lymphocytes. J. Immunol. 160:3322‐3329.
   Wade, W.F., Chen, Z.Z., Maki, R., McKercher, S., Palmer, E., Cambier, J.C., and Freed, J.H. 1989. Altered I‐A protein‐mediated transmembrane signaling in B cells that express truncated I‐Ak protein. Proc. Natl. Acad. Sci. U.S.A. 86:6297‐6301.
   Wang, D., Feng J., Wen, R., Marine, J.C., Sangster, M.Y., Parganas, E., Hoffmeyer, A., Jackson, C.W., Cleveland, J.L., Murray, P.J., and Ihle, J.N. 2000. Phospholipase Cγ2 is essential in the functions of B cell and several Fc receptors. Immunity 13:25‐35.
   Wu, H.‐J. and Bondada, S. 2002. Positive and negative roles of CD72 in B cell function. Immunol. Res. 25:155‐66.
GO TO THE FULL PROTOCOL:
PDF or HTML at Wiley Online Library